Cargando…
P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN PATIENTS WITH MYELOFIBROSIS
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431423/ http://dx.doi.org/10.1097/01.HS9.0000970996.87048.d4 |
| _version_ | 1785091197627269120 |
|---|---|
| author | Harrison, Claire Mascarenhas, John Cilloni, Daniela Schlenk, Richard Jacoby, Brian Slack, Robert J Aslanis, Vassilios Singh, Bhupinder Lindmark, Bertil Verstovsek, Srdan Rampal, Raajit K |
| author_facet | Harrison, Claire Mascarenhas, John Cilloni, Daniela Schlenk, Richard Jacoby, Brian Slack, Robert J Aslanis, Vassilios Singh, Bhupinder Lindmark, Bertil Verstovsek, Srdan Rampal, Raajit K |
| author_sort | Harrison, Claire |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431423 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104314232023-08-17 P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN PATIENTS WITH MYELOFIBROSIS Harrison, Claire Mascarenhas, John Cilloni, Daniela Schlenk, Richard Jacoby, Brian Slack, Robert J Aslanis, Vassilios Singh, Bhupinder Lindmark, Bertil Verstovsek, Srdan Rampal, Raajit K Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431423/ http://dx.doi.org/10.1097/01.HS9.0000970996.87048.d4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Harrison, Claire Mascarenhas, John Cilloni, Daniela Schlenk, Richard Jacoby, Brian Slack, Robert J Aslanis, Vassilios Singh, Bhupinder Lindmark, Bertil Verstovsek, Srdan Rampal, Raajit K P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN PATIENTS WITH MYELOFIBROSIS |
| title | P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN PATIENTS WITH MYELOFIBROSIS |
| title_full | P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN PATIENTS WITH MYELOFIBROSIS |
| title_fullStr | P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN PATIENTS WITH MYELOFIBROSIS |
| title_full_unstemmed | P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN PATIENTS WITH MYELOFIBROSIS |
| title_short | P1024: MYLOX-1: A PHASE II STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR GB2064 (WITH FOCUS ON BONE MARROW COLLAGEN) IN PATIENTS WITH MYELOFIBROSIS |
| title_sort | p1024: mylox-1: a phase ii study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of oral loxl2 inhibitor gb2064 (with focus on bone marrow collagen) in patients with myelofibrosis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431423/ http://dx.doi.org/10.1097/01.HS9.0000970996.87048.d4 |
| work_keys_str_mv | AT harrisonclaire p1024mylox1aphaseiistudyevaluatingthesafetytolerabilitypharmacokineticsandpharmacodynamicsoforalloxl2inhibitorgb2064withfocusonbonemarrowcollageninpatientswithmyelofibrosis AT mascarenhasjohn p1024mylox1aphaseiistudyevaluatingthesafetytolerabilitypharmacokineticsandpharmacodynamicsoforalloxl2inhibitorgb2064withfocusonbonemarrowcollageninpatientswithmyelofibrosis AT cillonidaniela p1024mylox1aphaseiistudyevaluatingthesafetytolerabilitypharmacokineticsandpharmacodynamicsoforalloxl2inhibitorgb2064withfocusonbonemarrowcollageninpatientswithmyelofibrosis AT schlenkrichard p1024mylox1aphaseiistudyevaluatingthesafetytolerabilitypharmacokineticsandpharmacodynamicsoforalloxl2inhibitorgb2064withfocusonbonemarrowcollageninpatientswithmyelofibrosis AT jacobybrian p1024mylox1aphaseiistudyevaluatingthesafetytolerabilitypharmacokineticsandpharmacodynamicsoforalloxl2inhibitorgb2064withfocusonbonemarrowcollageninpatientswithmyelofibrosis AT slackrobertj p1024mylox1aphaseiistudyevaluatingthesafetytolerabilitypharmacokineticsandpharmacodynamicsoforalloxl2inhibitorgb2064withfocusonbonemarrowcollageninpatientswithmyelofibrosis AT aslanisvassilios p1024mylox1aphaseiistudyevaluatingthesafetytolerabilitypharmacokineticsandpharmacodynamicsoforalloxl2inhibitorgb2064withfocusonbonemarrowcollageninpatientswithmyelofibrosis AT singhbhupinder p1024mylox1aphaseiistudyevaluatingthesafetytolerabilitypharmacokineticsandpharmacodynamicsoforalloxl2inhibitorgb2064withfocusonbonemarrowcollageninpatientswithmyelofibrosis AT lindmarkbertil p1024mylox1aphaseiistudyevaluatingthesafetytolerabilitypharmacokineticsandpharmacodynamicsoforalloxl2inhibitorgb2064withfocusonbonemarrowcollageninpatientswithmyelofibrosis AT verstovseksrdan p1024mylox1aphaseiistudyevaluatingthesafetytolerabilitypharmacokineticsandpharmacodynamicsoforalloxl2inhibitorgb2064withfocusonbonemarrowcollageninpatientswithmyelofibrosis AT rampalraajitk p1024mylox1aphaseiistudyevaluatingthesafetytolerabilitypharmacokineticsandpharmacodynamicsoforalloxl2inhibitorgb2064withfocusonbonemarrowcollageninpatientswithmyelofibrosis |